179 related articles for article (PubMed ID: 22316149)
1. In silico lead identification and optimization for drug discovery.
Zhang S
Curr Pharm Des; 2012; 18(9):1171-2. PubMed ID: 22316149
[No Abstract] [Full Text] [Related]
2. Computational chemistry at Janssen.
van Vlijmen H; Desjarlais RL; Mirzadegan T
J Comput Aided Mol Des; 2017 Mar; 31(3):267-273. PubMed ID: 27995515
[TBL] [Abstract][Full Text] [Related]
3. What is the most important approach in current drug discovery: doing the right things or doing things right?
Elebring T; Gill A; Plowright AT
Drug Discov Today; 2012 Nov; 17(21-22):1166-9. PubMed ID: 22569181
[TBL] [Abstract][Full Text] [Related]
4. Have microfluidics delivered for drug discovery?
Chandrasekaran A; Abduljawad M; Moraes C
Expert Opin Drug Discov; 2016 Aug; 11(8):745-8. PubMed ID: 27266956
[No Abstract] [Full Text] [Related]
5. To measure is to know: an approach to CADD performance metrics.
Loughney D; Claus BL; Johnson SR
Drug Discov Today; 2011 Jul; 16(13-14):548-54. PubMed ID: 21605697
[TBL] [Abstract][Full Text] [Related]
6. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
Betz UA
Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
[TBL] [Abstract][Full Text] [Related]
7. Computer-aided drug discovery research at a global contract research organization.
Kitchen DB
J Comput Aided Mol Des; 2017 Mar; 31(3):309-318. PubMed ID: 27804014
[TBL] [Abstract][Full Text] [Related]
8. Current insights into computer-aided immunotherapeutic design strategies.
Cai Z; Zhang G; Zhang X; Liu Y; Fu X
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):278-85. PubMed ID: 26091813
[TBL] [Abstract][Full Text] [Related]
9. Alternative business models for drug discovery.
Bunin BA; Ekins S
Drug Discov Today; 2011 Aug; 16(15-16):643-5. PubMed ID: 21745585
[No Abstract] [Full Text] [Related]
10. Q&A: Bernard Munos.
Bender E
Nature; 2016 May; 533(7602):S59. PubMed ID: 27167392
[No Abstract] [Full Text] [Related]
11. In silico drug discovery approaches on grid computing infrastructures.
Wolf A; Shahid M; Kasam V; Ziegler W; Hofmann-Apitius M
Curr Clin Pharmacol; 2010 Feb; 5(1):37-46. PubMed ID: 19642967
[TBL] [Abstract][Full Text] [Related]
12. The need for scientific software engineering in the pharmaceutical industry.
Luty B; Rose PW
J Comput Aided Mol Des; 2017 Mar; 31(3):301-304. PubMed ID: 27995514
[TBL] [Abstract][Full Text] [Related]
13. Welcome to 'microdosing'.
Ings RM
Bioanalysis; 2010 Mar; 2(3):371-2. PubMed ID: 21083244
[No Abstract] [Full Text] [Related]
14. Tools, techniques, organisation and culture of the CADD group at Sygnature Discovery.
St-Gallay SA; Sambrook-Smith CP
J Comput Aided Mol Des; 2017 Mar; 31(3):305-308. PubMed ID: 27798721
[TBL] [Abstract][Full Text] [Related]
15. Competition: Unlikely partnerships.
Savage N
Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
[No Abstract] [Full Text] [Related]
16. Tropical disease: A neglected cause.
Laursen L
Nature; 2016 May; 533(7602):S68-9. PubMed ID: 27167396
[No Abstract] [Full Text] [Related]
17. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
Thomas CE; Will Y
Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
[TBL] [Abstract][Full Text] [Related]
18. Molecular topology as a novel approach for drug discovery.
Gálvez J; Gálvez-Llompart M; García-Domenech R
Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
[TBL] [Abstract][Full Text] [Related]
19. Efficient and effective compound management to support lead optimization.
Johnson CW; Chatterjee M; Kubala S; Helm D; Houston J; Banks M
J Biomol Screen; 2009 Jun; 14(5):523-30. PubMed ID: 19483145
[TBL] [Abstract][Full Text] [Related]
20. Fragment-based lead discovery grows up.
Baker M
Nat Rev Drug Discov; 2013 Jan; 12(1):5-7. PubMed ID: 23274457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
